Carregant...
CMET-24. NEXT-GENERATION EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE INHIBITORS FOR LEPTOMENINGEAL CARCINOMATOSIS
EGFR mutation status is strongly correlated with leptomeningeal carcinomatosis in non-small-cell lung cancer. Historically, patients were treated with first-generation EGFR tyrosine kinase inhibitors, however most would eventually develop resistance and disease progression. Therefore, recent interes...
Guardat en:
| Publicat a: | Neuro Oncol |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Oxford University Press
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6216919/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy148.236 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|